Introduction {#Sec1}
============

The contribution of respiratory viruses to hospitalisation of children is often unclear. Viral emergence varies on a seasonal and annual basis, and the exact demographic characteristics of children affected are often unknown. Moreover, many viral infections are missed during routine laboratory diagnosis due to the poor quality of many clinical specimens, the lack of sensitivity of rapid antigen detection tests, and the prohibitively high cost of reverse transcriptase-PCR methods, which limits their use. The very high sensitivity of PCR methods is problematic because it is difficult to distinguish between residual genetic material from previous infections and the replicating viruses in an acute infection. Thus, nucleic acid detection methods, when used alone, may be difficult to interpret in cases of dual or multiple infections. Recent publications have shown that respiratory viruses may persist, without causing symptoms, for prolonged periods of time in the nasopharyngeal tract; in addition, noninfective viral nucleic acids from rhinovirus or respiratory syncytial virus (RSV) can be detected in humans or animal models for up to several months after infection \[[@CR1], [@CR2]\].

The recently described human metapneumovirus (hMPV) has been suggested to be less pathogenic than RSV, on the basis of hospitalisation rates and duration of symptoms of the patients affected \[[@CR3], [@CR4]\]. The impact of hMPV on the overall paediatric respiratory disease burden is still under investigation, and the role of hMPV in increasing the severity of RSV infection remains controversial \[[@CR5], [@CR6]\].

Another new virus family, the *Mimiviridae*, was first described in water amoebae obtained from a British cooling tower. These huge DNA viruses (400 nm diameter) were first though to be small bacteria and were thus named after their ability to "mimic" a microbe. Although there is no definitive evidence that they are pathogenic in humans, recent data suggests that they can be transmitted to humans because mimivirus DNA was found in broncheoalveolar specimens of ICU patients \[[@CR7]\]. Moreover, serologic evidence of infection was observed in 5 of 26 (19.2%) ICU patients in the same study. We included this new virus in our preliminary study because there are currently no data available in paediatric patients.

Materials and methods {#Sec2}
=====================

Origin of respiratory samples {#Sec3}
-----------------------------

A total of 214 nasopharyngeal aspirate samples were collected between the last week of September and 31 March at the local paediatrics department. Two hundred nine originated from nonimmunocompromised children who had been hospitalised for respiratory tract infections of different severity, and five originated from immunocompromised children. Of the immunocompromised children, two had undergone renal transplantation and one had received a heart transplant. Most of the children were admitted to hospital because of bronchiolitis, bronchitis, or pneumonia. Five children had malformities that involved the thorax or lungs or that necessitated oxygen therapy over longer periods of time. One child had cystic fibrosis.

Detection of viral antigen from respiratory specimens {#Sec4}
-----------------------------------------------------

For detection of RSV, the Pathfinder RSV antigen test (Bio-Rad, Hercules, CA, USA) was used. Influenza A and B antigen was detected with Flu-Directigen FluA+B (Becton Dickinson, Franklin Lakes, NJ, USA). To detect adenovirus, PCR was used in addition to the Premier Adenoclone kit (Meridian, Bioscience, Cincinnati, OH, USA).

Isolation of viruses {#Sec5}
--------------------

The human epithelial cell line HEp-2 (ATCC CCL-23) and the monkey kidney cell line MA-104 (ATCC CRL-2378) were used for culture of viruses. HEp-2 was preferred, since a recent study showed that these cells were superior to the rhesus monkey kidney cells (LLC-MK2) commonly used in previous studies for isolation of hMPV, especially if used in conjunction with a molecular method to detect hMPV, performed as a follow-up to cell culture \[[@CR8]\]. HEp-2 laryngeal carcinoma cells, which, according to ATCC genetic analyses are contaminated by HeLa cells, also support the growth of adenoviruses, RSV, and some rhinoviruses, although rhinoviruses were not targeted in this study. The MA-104 line, which, according to recent genetic analysis at the ATCC, is a mixture of rhesus monkey kidney and African green monkey kidney cells, was chosen due its proven capability to grow parainfluenza viruses, SARS coronavirus, avian pneumoviruses, and a broad range of enteric viruses.

One millilitre of nasopharyngeal aspirates was filtered through sterile 0.44-μm membrane filters (Millipore, Billerica, MA, USA), inoculated into cell cultures, and allowed to stand for 1 day. Thereafter, the medium was removed and the cells cultured in DMEM with 2% foetal calf serum for 2 weeks for the HEp-2 cells and for 4 weeks for the MA-104 cells. Afterwards, culture tubes were frozen irrespective of any cytopathic effects observed.

Preparation of samples and controls {#Sec6}
-----------------------------------

Two ml of supernatant from freeze--thawed cell cultures, which corresponds to approximately 5 × 10^5^ cells, was processed with the QIAmp UltraSens virus kit (Qiagen, Valencia, CA, USA) and viral RNA/DNA eluted in 50 μl of H~2~O. Ten μl of the extracted RNA was reverse-transcribed using the SuperScript III Platinum RT kit (Invitrogen, Carlsbad, CA, USA) and random hexameres according to the manufacturer's protocol. As positive controls, an enteric adenovirus isolate from stool (type 41) and parainfluenza virus types 1 (ATCC VR-94) and 3 (ATCC VR-93) were used. cDNA from hMPV was kindly provided by Dr. Barbara Huck, Freiburg, Germany.

PCR testing {#Sec7}
-----------

Parainfluenza-virus- and adenovirus-specific PCR tests were performed in accordance with published protocols \[[@CR9]\]. A PCR test for hMPV, which detects all hMPV lineages known thus far, has been described recently \[[@CR10]\]. A PCR protocol suitable for detection of *Mimiviridae* in respiratory samples was kindly provided by D. Raoult, Marseille, France. To avoid specimen contamination during detection of such a rare pathogen, a "suicide PCR" protocol was used, which was described previously by the same group for detection of *Yersinia pestis*, the agent of medieval black death \[[@CR11]\]. In the suicide PCR, primers are used only once, and there are no positive controls introduced into the laboratory. A negative test result is followed by a new test using other primers; a positive result is followed by sequencing. Although this procedure restricts sensitivity of detection of mimivirus to a certain extent, it provides absolute specificity by avoiding cross-contamination \[[@CR7]\].

DNA sequencing {#Sec8}
--------------

For typing of certain isolates of parainfluenza virus, hMPV, and adenovirus, DNA sequencing using an Applied Biosystems ABI 3100 automated sequencer (Applied Biosystems, Foster City, CA, USA) was used to further characterise the strains. The sequences obtained were compared to published sequences from the Genbank database using the BLAST search algorithm.

Results {#Sec9}
=======

Influenza virus {#Sec10}
---------------

Only influenza A virus was detected in children younger than 3 years (mean age of infection, 14.6 months). The main influenza A peak ranged from mid-November to the end of February (Fig. [1](#Fig1){ref-type="fig"}). Two dual infections, one with RSV and one with adenovirus, were observed. Fig. 1Graphical outline of respiratory samples that tested positive for viruses, with each week of detection depicted. *Columns* represent cumulative samples detected within 1 week, with the abscissae indicating the respective months from the last week of September to the end of March. The ordinates show the numbers of positive samples. Viruses investigated in this study are, from the top, influenza virus, parainfluenza virus, human metapneumovirus (hMPV), respiratory syncytial virus (RSV) and adenovirus (adeno). Mimivirus was also investigated, but none was detected. The total number of samples received/tested weekly is shown in the bottom graph (*empty bars*) for comparison

Parainfluenza virus {#Sec11}
-------------------

A seasonal peak from September to mid-November, which ended abruptly before the influenza A outbreak, was observed. Only a single case of PIV1 infection was detected within the main influenza A season (Fig. [1](#Fig1){ref-type="fig"}). Four samples from the PIV1 outbreak, including the sample from December, were confirmed by sequencing as having the PIV1 genotype. Most cases of parainfluenza virus infection occurred in children younger than 2 years (mean age of infection, 8.7 months) (Table [1](#Tab1){ref-type="table"}). Two cases were observed in children older than 5 years: one in an ICU patient, and the other in a patient with lung malformation. Table 1Mean age of children infected with influenza A virus, adenovirus, human metapneumovirus (*hMPV*), parainfluenza virus 1 (*PIV1*), and respiratory syncytial virus (*RSV*)VirusMean age of infected children (months)Influenza A virus14.6Adenovirus12.2hMPV10.1PIV18.7RSV5.8

Adenovirus {#Sec12}
----------

Only four cases of adenovirus infection were detected in our hospitalised population: two were detected by PCR and two by the antigen test. All children with adenovirus infection were younger than 2 years (mean age of infection, 12.2 months) (Table [1](#Tab1){ref-type="table"}). One dual infection of adenovirus type 2 (confirmed by sequencing) and influenza A occurred in a 10-month-old child.

Respiratory syncytial virus {#Sec13}
---------------------------

No larger RSV epidemics were detected in hospitalised infants in our region during the time period studied (Fig. [1](#Fig1){ref-type="fig"}). Most cases of RSV infection occurred in children younger than 1 year (mean age of infection, 5.8 months), although three cases occurred in children older than 5 years (Table [1](#Tab1){ref-type="table"}). Only three dual infections were observed, two with hMPV (1 of which occurred in a child undergoing respirator treatment) and one with influenza A virus.

Human metapneumovirus {#Sec14}
---------------------

Numerous isolates of hMPV were recovered from September to November, but the virus was almost absent during the influenza season. A small peak caused by isolates of the identical genotype was also observed in March (Fig. [1](#Fig1){ref-type="fig"}). In total, 31 of 214 (14.5%) samples were positive for hMPV, of which 29 originated from nonimmunocompromised children. Most cases occurred in children younger than 2 years (mean age of infection, 10.1 months), with more than 50% of the children affected being under 6 months of age (Table [2](#Tab2){ref-type="table"}). Five dual infections were noted, three with PIV1 and two with RSV. No dual infections with influenza A virus or adenovirus were detected. One 15-year-old boy acquired a coinfection with RSV while recovering from enteroviral meningitis. Table 2Age distribution of the 214 children in the study group and of the 29 hMPV-positive childrenAge rangeNo. of childrenAll children in studyhMPV-positive children\<6 months83 (39%)156 months to 1 year49 (23%)41--2 years43 (20%)42--4 years16 (7%)4\>4 years23 (11%)2

Mimivirus {#Sec15}
---------

Mimivirus was not detected in any of the respiratory samples tested. Moreover, several amoeba-containing samples from water tanks in Austria as well as from Thailand all tested negative in the mimivirus-specific suicide PCR (data not shown).

Discussion {#Sec16}
==========

Since the clinical relevance of PCR findings in respiratory samples is not always clear due to detection of residual genetic material \[[@CR1], [@CR2]\], we employed a combination of cell culture and PCR to detect actively replicating respiratory viruses in this epidemiological investigation. The combination of HEp-2 and MA-104 cells for viral culture enabled detection of not only numerous hMPV and parainfluenza virus isolates but also adenovirus and even rhinovirus isolates (data not shown). The cell types chosen are not optimal for the culture of rhinovirus, but that was not of primary interest in our investigation. In addition, influenza virus, RSV, and adenoviruses were detected in nasopharyngeal aspirates by commercial antigen detection assays.

The rather strict separation of the PIV1 outbreak and the influenza A outbreak, with one virus completely replacing the other one in the community with almost no overlap, was an interesting observation. In contrast, RSV was also detected throughout the influenza A period, yet in the particular year studied, no pronounced RSV epidemic was observed in our patients. This is probably due to the low birth rate, which results in sufficient numbers of susceptible individuals necessary for efficient transmission kinetics only every 2--3 years. In contrast, in countries with higher birth rates, strong RSV outbreaks seem to occur on an annual basis, with numbers of cases far exceeding the hMPV cases \[[@CR12]\]. Furthermore, the relatively low overall population density and rural character of our region may play a role, since increases in the incidence of RSV and influenza A virus have been correlated with urbanisation in long-term epidemiological surveys \[[@CR13]\].

During the peak season of influenza A, there were no isolations of hMPV in our paediatric study group. The very few isolations of hMPV in this time period were obtained in our laboratory from adult lung transplant patients only. In these immunocompromised patients, prolonged persistence of hMPV is observed, and a different virus subtype has even been sequenced in the interepidemic time period \[[@CR14]\]. The latter finding could be an indication for independently transmitted hMPV strains within the hospital environment (nosocomial infections?), which, in adult transplant patients, may lead to rather severe sequelae \[[@CR14]\].

The coincidence of the community outbreak of PIV1 with the peak incidence of hMPV was obvious, a situation that was also observed in the following year in the nearby South Tyrolean region (unpublished observation). Whether this might indicate similar physico/chemical properties of the two viruses and/or comparable means of transmission remains to be clarified. As most of the dual infections observed were a combination of PIV1 and hMPV, one could also speculate that a possible synergy between these viruses might exist, leading to cocirculation in the community. Some investigators, who have reported the frequent detection of hMPV in combination with the SARS virus, have recently proposed such a concept \[[@CR8]\]. hMPV coinfection was suspected to enhance the early transmission of the less contagious coronavirus, thus contributing to the development of so-called "superspreaders" \[[@CR15]\].

It is not clear at present whether dual infections contribute to the severity of symptoms and the rate of hospitalisation. In a recent multicentre study in Germany, König et al. \[[@CR5]\] reported that only 1% of all hMPV infections were observed in children who did not require ICU support, yet among children in the ICU, hMPV was detected in 30%, with an impressive 60% of hMPV infections being associated with RSV infection. The relatively low number of RSV dual infections in our study could also be due to the reduced sensitivity of the commercial RSV antigen detection test as compared to PCR methods, but the data are difficult to compare because the König study, in contrast to ours, did not target actively replicating virus but instead detected nucleic acid material in nasopharyngeal samples directly. Thus, the amplification of residual genetic material from previous infections remains an obstacle when interpreting the results of highly sensitive PCR methods \[[@CR1], [@CR2]\]. Since the majority of hMPV isolations in our study were not coinfections with other viruses and the overall number of hospitalised children in whom hMPV was the only virus detected was relatively high (14%), we do not have any reason to assume that this particular hMPV strain is less virulent than RSV. However, recent data suggests that, in Italy, RSV is associated with higher hospitalisation rates than hMPV \[[@CR3]\]. In addition, a significantly longer duration of symptoms has been reported for RSV compared with hMPV \[[@CR4]\].

Only a few respiratory adenoviruses (type 2) were detected with both PCR and the antigen detection assays, which leads us to conclude that children with respiratory adenovirus strains are rarely hospitalised in our population.

Mimiviruses were not detected at all in our study, which, retrospectively, is not too surprising. According to the most recent publication by LaScola et al. \[[@CR7]\], who discovered the mimiviruses, these viruses seem to be found only in severely ill ICU patients, which does not describe most of our paediatric study group. Since mimiviruses also were not detected in several samples of amoebae-containing water obtained from water tanks, one can assume that this particular virus subtype is either not highly abundant or is subject to regional variances in prevalence that have not yet been studied. In conclusion, this first investigation of *Mimiviridae* in paediatric patients demonstrates that, at present, there is no indication that mimiviruses contribute significantly to paediatric respiratory illness in Austria.
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